{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:32:24Z","timestamp":1788885144636,"version":"build-2803163510"},"reference-count":78,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2021,3,27]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Asthma and COPD continue to cause considerable diagnostic and treatment stratification challenges. Volatile organic compounds (VOCs) have been proposed as feasible diagnostic and monitoring biomarkers in airway diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To 1) conduct a systematic review evaluating the diagnostic accuracy of VOCs in diagnosing airway diseases; 2) understand the relationship between reported VOCs and biomarkers of type-2 inflammation; 3) assess the standardisation of reporting according to STARD and TRIPOD criteria; 4) review current methods of breath sampling and analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A PRISMA-oriented systematic search was conducted (January 1997 to December 2020). Search terms included: \u201casthma\u201d, \u201cvolatile organic compound(s)\u201d, \u201cVOC\u201d and \u201cCOPD\u201d. Two independent reviewers examined the extracted titles against review objectives.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>44 full-text papers were included; 40\/44 studies were cross-sectional and four studies were interventional in design; 17\/44 studies used sensor-array technologies (<jats:italic>e.g.<\/jats:italic>eNose). Cross-study comparison was not possible across identified studies due to the heterogeneity in design. The commonest airway diseases differentiating VOCs belonged to carbonyl-containing classes (<jats:italic>i.e.<\/jats:italic>aldehydes, esters and ketones) and hydrocarbons (<jats:italic>i.e.<\/jats:italic>alkanes and alkenes). Although individual markers that are associated with clinical biomarkers of type-2 inflammation were recognised (<jats:italic>i.e.<\/jats:italic>ethane and 3,7-dimethylnonane for asthma and \u03b1-methylstyrene and decane for COPD), these were not consistently identified across studies. Only 3\/44 reported following STARD or TRIPOD criteria for diagnostic accuracy and multivariate reporting, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Breath VOCs show promise as diagnostic biomarkers of airway diseases and for type-2 inflammation profiling. However, future studies should focus on transparent reporting of diagnostic accuracy and multivariate models and continue to focus on chemical identification of volatile metabolites.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00030-2021","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T17:47:09Z","timestamp":1617904029000},"page":"00030-2021","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["A systematic review of the diagnostic accuracy of volatile organic compounds in airway diseases and their relation to markers of type-2 inflammation"],"prefix":"10.1183","volume":"7","author":[{"given":"Wadah","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushiladevi","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0726-890X","authenticated-orcid":false,"given":"Michael","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cordell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9984-4390","authenticated-orcid":false,"given":"Paul S.","family":"Monks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Greening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Brightling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-868X","authenticated-orcid":false,"given":"Rachael","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"2024101711084992000_7.3.00030-2021.1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","article-title":"Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"5","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024101711084992000_7.3.00030-2021.2","first-page":"76","article-title":"COPD and asthma: diagnostic accuracy requires spirometry","volume":"68","author":"Wells","year":"2019","journal-title":"J Fam Pract"},{"key":"2024101711084992000_7.3.00030-2021.3","doi-asserted-by":"publisher","DOI":"10.1186\/2045-7022-3-37"},{"key":"2024101711084992000_7.3.00030-2021.4","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.2174\/1389450119666180212120012","article-title":"Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD","volume":"19","author":"Kostikas","year":"2018","journal-title":"Curr Drug Targets"},{"key":"2024101711084992000_7.3.00030-2021.5","doi-asserted-by":"publisher","DOI":"10.1080\/02770900500448738"},{"key":"2024101711084992000_7.3.00030-2021.6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12948-015-0032-x","article-title":"Asthma under\/misdiagnosis in primary care setting: an observational community-based study in Italy","volume":"13","author":"Magnoni","year":"2015","journal-title":"Clin Mol Allergy"},{"key":"2024101711084992000_7.3.00030-2021.7","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0362-2018"},{"key":"2024101711084992000_7.3.00030-2021.8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13223-017-0219-4","article-title":"Asthma biomarkers in the age of biologics","volume":"13","author":"Kim","year":"2017","journal-title":"Allergy, Asthma Clin Immunol"},{"key":"2024101711084992000_7.3.00030-2021.9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cea.12881","article-title":"The current and future role of biomarkers in type 2 cytokine-mediated asthma management","volume":"47","author":"Pavord","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"2024101711084992000_7.3.00030-2021.10","unstructured":"National Institute for Health and Care Excellence . Asthma: diagnosis, monitoring and chronic asthma management (NICE guideline [NG80]). 2020. www.nice.org.uk\/guidance\/ng80."},{"key":"2024101711084992000_7.3.00030-2021.11","first-page":"399","article-title":"Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects","volume":"10:","author":"Besa","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101711084992000_7.3.00030-2021.12","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.156695"},{"key":"2024101711084992000_7.3.00030-2021.13","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.cardfail.2011.06.012","article-title":"Single breath exhaled gas analysis by selected ion-flow tube mass-spectrometry (SIFT-MS) in patients with acute decompensated heart failure","volume":"17","author":"Samara","year":"2011","journal-title":"J Cardiac Fail"},{"key":"2024101711084992000_7.3.00030-2021.14","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1836"},{"key":"2024101711084992000_7.3.00030-2021.15","first-page":"A2373","article-title":"Exhaled volatile organic compounds are able to discriminate between neutrophilic and eosinophilic asthma","volume":"201","author":"Schleich","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711084992000_7.3.00030-2021.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.10.018"},{"key":"2024101711084992000_7.3.00030-2021.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2008.08.008"},{"key":"2024101711084992000_7.3.00030-2021.18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1465-9921-13-72","article-title":"Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study","volume":"13","author":"Basanta","year":"2012","journal-title":"Respir Res"},{"key":"2024101711084992000_7.3.00030-2021.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012799"},{"key":"2024101711084992000_7.3.00030-2021.20","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0698"},{"key":"2024101711084992000_7.3.00030-2021.21","doi-asserted-by":"publisher","DOI":"10.1059\/0003-4819-155-8-201110180-00009"},{"key":"2024101711084992000_7.3.00030-2021.22","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/cea.12965","article-title":"Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma","volume":"47","author":"Brinkman","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"2024101711084992000_7.3.00030-2021.23","first-page":"A3946","article-title":"Predicting steroid responsiveness in patients with asthma using the electronic nose","volume":"185","author":"van Der Schee","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101711084992000_7.3.00030-2021.24","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.3390\/s101009127","article-title":"Electronic nose breathprints are independent of acute changes in airway caliber in asthma","volume":"10","author":"Lazar","year":"2010","journal-title":"Sensors (Basel)"},{"key":"2024101711084992000_7.3.00030-2021.25","doi-asserted-by":"crossref","first-page":"036022","DOI":"10.1088\/1752-7163\/aac273","article-title":"Cluster analysis on breath print of newly diagnosed COPD patients: effects of therapy","volume":"12","author":"Scarlata","year":"2018","journal-title":"J Breath Res"},{"key":"2024101711084992000_7.3.00030-2021.26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.4.862"},{"key":"2024101711084992000_7.3.00030-2021.27","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12147"},{"key":"2024101711084992000_7.3.00030-2021.28","doi-asserted-by":"crossref","first-page":"e0135199","DOI":"10.1371\/journal.pone.0135199","article-title":"Using the electronic nose to identify airway infection during COPD exacerbations","volume":"10","author":"Shafiek","year":"2015","journal-title":"PLoS ONE"},{"key":"2024101711084992000_7.3.00030-2021.29","doi-asserted-by":"crossref","first-page":"036002","DOI":"10.1088\/1752-7163\/aaa4c5","article-title":"Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease","volume":"12","author":"Pizzini","year":"2018","journal-title":"J Breath Res"},{"key":"2024101711084992000_7.3.00030-2021.30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.chest.2018.12.023","article-title":"Real-time breath analysis reveals specific metabolic signatures of COPD exacerbations","volume":"156","author":"Gaugg","year":"2019","journal-title":"Chest"},{"key":"2024101711084992000_7.3.00030-2021.31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/15412555.2019.1669550","article-title":"Exhaled breath profiles before, during and after exacerbation of COPD: a prospective follow-up study","volume":"16","author":"van Velzen","year":"2019","journal-title":"COPD"},{"key":"2024101711084992000_7.3.00030-2021.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.05.043"},{"key":"2024101711084992000_7.3.00030-2021.33","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.4.2003064"},{"key":"2024101711084992000_7.3.00030-2021.34","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jaci.2018.10.058","article-title":"Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma","volume":"143","author":"Brinkman","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2024101711084992000_7.3.00030-2021.35","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/6\/3\/036003"},{"key":"2024101711084992000_7.3.00030-2021.36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40749-015-0010-1","article-title":"Analysis of exhaled breath fingerprints and volatile organic compounds in COPD","volume":"1","author":"Cazzola","year":"2015","journal-title":"COPD Res Pract"},{"key":"2024101711084992000_7.3.00030-2021.37","doi-asserted-by":"crossref","first-page":"e4684","DOI":"10.1002\/bmc.4684","article-title":"Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: a pilot study","volume":"33","author":"Rodr\u00edguez-Aguilar","year":"2019","journal-title":"Biomed Chromatogr"},{"key":"2024101711084992000_7.3.00030-2021.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03800.x"},{"key":"2024101711084992000_7.3.00030-2021.39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/1354750X.2018.1508307","article-title":"Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma","volume":"24","author":"Dragonieri","year":"2019","journal-title":"Biomarkers"},{"key":"2024101711084992000_7.3.00030-2021.40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12127-011-0081-x","article-title":"Statistical and bioinformatical methods to differentiate chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control by breath analysis using ion mobility spectrometry","volume":"14","author":"Westhoff","year":"2011","journal-title":"Int J Ion Mobil Spectrom"},{"key":"2024101711084992000_7.3.00030-2021.41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12127-010-0049-2","article-title":"Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry","volume":"13","author":"Westhoff","year":"2010","journal-title":"Int J Ion Mobil Spectrom"},{"key":"2024101711084992000_7.3.00030-2021.42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.arbr.2017.03.007","article-title":"Study of 5 volatile organic compounds in exhaled breath in chronic obstructive pulmonary disease","volume":"53","author":"Jareno-Esteban","year":"2017","journal-title":"Arch Bronconeumol"},{"key":"2024101711084992000_7.3.00030-2021.43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/metabo4020300","article-title":"Short-term intra-subject variation in exhaled volatile organic compounds (VOCs) in COPD patients and healthy controls and its effect on disease classification","volume":"4","author":"Phillips","year":"2014","journal-title":"Metabolites"},{"key":"2024101711084992000_7.3.00030-2021.44","doi-asserted-by":"crossref","first-page":"017113","DOI":"10.1088\/1752-7155\/7\/1\/017113","article-title":"A mobile instrumentation platform to distinguish airway disorders","volume":"7","author":"Schivo","year":"2013","journal-title":"J Breath Res"},{"key":"2024101711084992000_7.3.00030-2021.45","first-page":"PA3987","article-title":"Breathe free: open source development of a breath sampler by a consortium of breath researchers","volume":"46","author":"Kitchen","year":"2015","journal-title":"Eur Respir J"},{"key":"2024101711084992000_7.3.00030-2021.46","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00119-2020"},{"key":"2024101711084992000_7.3.00030-2021.47","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(89)90102-0"},{"key":"2024101711084992000_7.3.00030-2021.48","doi-asserted-by":"crossref","first-page":"026006","DOI":"10.1088\/1752-7155\/10\/2\/026006","article-title":"A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD","volume":"10","author":"Gaida","year":"2016","journal-title":"J Breath Res"},{"key":"2024101711084992000_7.3.00030-2021.49","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00056-2019"},{"key":"2024101711084992000_7.3.00030-2021.50","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/cancers11060831","article-title":"Breath analysis: a systematic review of volatile organic compounds (VOCs) in diagnostic and therapeutic management of pleural mesothelioma","volume":"11","author":"Catino","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2024101711084992000_7.3.00030-2021.51","doi-asserted-by":"crossref","first-page":"034002","DOI":"10.1088\/1752-7155\/10\/3\/034002","article-title":"A systematic review of breath analysis and detection of volatile organic compounds in COPD","volume":"10","author":"Christiansen","year":"2016","journal-title":"J Breath Res"},{"key":"2024101711084992000_7.3.00030-2021.52","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3390\/ijerph17031110","article-title":"Exhaled breath analysis in diagnosis of malignant pleural mesothelioma: systematic review","volume":"17","author":"T\u00f6reyin","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2024101711084992000_7.3.00030-2021.53","doi-asserted-by":"crossref","first-page":"046008","DOI":"10.1088\/1752-7163\/aba130","article-title":"A benchmarking protocol for breath analysis: the peppermint experiment","volume":"14","author":"Henderson","year":"2020","journal-title":"J Breath Res"},{"key":"2024101711084992000_7.3.00030-2021.54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5527"},{"key":"2024101711084992000_7.3.00030-2021.55","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9736"},{"key":"2024101711084992000_7.3.00030-2021.56","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025486"},{"key":"2024101711084992000_7.3.00030-2021.57","doi-asserted-by":"crossref","first-page":"016004","DOI":"10.1088\/1752-7163\/aa8409","article-title":"The necessity of external validation in exhaled breath research: a case study of sarcoidosis","volume":"12","author":"Fijten","year":"2017","journal-title":"J Breath Res"},{"key":"2024101711084992000_7.3.00030-2021.58","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/2\/4\/046001"},{"key":"2024101711084992000_7.3.00030-2021.59","doi-asserted-by":"crossref","first-page":"046008","DOI":"10.1088\/1752-7155\/10\/4\/046008","article-title":"Storage stability of exhaled breath on Tenax TA","volume":"10","author":"Harshman","year":"2016","journal-title":"J Breath Res"},{"key":"2024101711084992000_7.3.00030-2021.60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2011.02047.x"},{"key":"2024101711084992000_7.3.00030-2021.61","first-page":"PA2099","article-title":"Effects of topical therapy on the breath pattern of patients with newly diagnosed COPD: an e-nose based study","volume":"46","author":"Scarlata","year":"2015","journal-title":"Eur Respir J"},{"key":"2024101711084992000_7.3.00030-2021.62","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2147\/COPD.S159684","article-title":"Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity","volume":"13","author":"Finamore","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101711084992000_7.3.00030-2021.63","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/cea.12052","article-title":"Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions","volume":"43","author":"Fens","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"2024101711084992000_7.3.00030-2021.64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02789178","article-title":"Serology and urea breath test in the diagnosis of H. pylori infection","volume":"11","author":"Hawtin","year":"1999","journal-title":"Mol Biotechnol"},{"key":"2024101711084992000_7.3.00030-2021.65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"2024101711084992000_7.3.00030-2021.66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1748-1716.2006.01624.x","article-title":"Determination of ethane, pentane and isoprene in exhaled air \u2013 effects of breath-holding, flow rate and purified air","volume":"189","author":"Larstad","year":"2007","journal-title":"Acta Physiol (Oxf)"},{"key":"2024101711084992000_7.3.00030-2021.67","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200906-0939OC"},{"key":"2024101711084992000_7.3.00030-2021.68","doi-asserted-by":"crossref","first-page":"016003","DOI":"10.1088\/1752-7155\/6\/1\/016003","article-title":"Detection of gastro-oesophageal reflux disease (GORD) in patients with obstructive lung disease using exhaled breath profiling","volume":"6","author":"Timms","year":"2012","journal-title":"J Breath Res"},{"key":"2024101711084992000_7.3.00030-2021.69","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12931-014-0136-8","article-title":"Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air","volume":"15","author":"Meyer","year":"2014","journal-title":"Respir Res"},{"key":"2024101711084992000_7.3.00030-2021.70","first-page":"431","article-title":"Inflammatory asthma phenotype discrimination using an electronic nose breath analyzer","volume":"25","author":"Plaza","year":"2015","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2024101711084992000_7.3.00030-2021.71","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01817-2017"},{"key":"2024101711084992000_7.3.00030-2021.72","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00544-2019"},{"key":"2024101711084992000_7.3.00030-2021.73","doi-asserted-by":"publisher","DOI":"10.1039\/b916374c"},{"key":"2024101711084992000_7.3.00030-2021.74","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/5\/4\/046009"},{"key":"2024101711084992000_7.3.00030-2021.75","doi-asserted-by":"publisher","DOI":"10.1159\/000357785"},{"key":"2024101711084992000_7.3.00030-2021.76","doi-asserted-by":"crossref","first-page":"026004","DOI":"10.1088\/1752-7155\/10\/2\/026004","article-title":"Measurement of exhaled volatile organic compounds from patients with chronic obstructive pulmonary disease (COPD) using closed gas loop GC-IMS and GC-APCI-MS","volume":"10","author":"Allers","year":"2016","journal-title":"J Breath Res"},{"key":"2024101711084992000_7.3.00030-2021.77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clinms.2018.02.003","article-title":"Real-time mass spectrometric identification of metabolites characteristic of chronic obstructive pulmonary disease in exhaled breath","volume":"7","author":"Bregy","year":"2018","journal-title":"Clin Mass Spectrom"},{"key":"2024101711084992000_7.3.00030-2021.78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045396"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00030-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:07:41Z","timestamp":1740373661000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00030-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":78,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,8,31]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1183\/23120541.00030-2021"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00030-2021","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]}}}